Issue link: https://www.e-digitaleditions.com/i/1527415
32 OctOber 2024 Inhalation Formulation, device and development services Vectura is a specialist inhalation CDMO with 25 years of experience helping customers bring complex inhaled medicines to market by integrating expert formulation and device development services to accel- erate inhaled products through the phases of drug development. With a range of technology platforms, including dry powder inhalers and smart nebulizers, Vectura offers flexibility and expertise to support pro- grams including preclinical safety studies, formula- tion development and device selection, scale-up and GMP product and device manufacturing. Vectura UK: +44 1249 667700 info@vectura.com www.vectura.com Bespoke inhaled formulation development i2c Pharmaceutical Services is a leading independent service provider to global pharma, medical technol- ogy and emerging companies for the development of inhaled formulations and efficient devices. i2c provides bespoke integrated services from ab initio development through clinical trials. i2c also offers Respitab ® ; this propellant-dispersible tablet is a cost-effective and innovative manufacturing platform that can facilitate transition to the next generation of pressurized metered dose inhalers (pMDIs). i2c Pharmaceutical Services UK: +44 2920 757865 www.i2cpharm.co.uk DPI development and manufacturing services Experic's experienced team provides customized spray drying, precision filling, analytical support and pack- aging solutions at clinical and commercial scale for reservoir and single-dose dry powder inhalation (DPI) products. From formulation development and GMP manufacturing in low humidity environments to clin- ical trial supplies and global logistics, Experic offers services that can solve development and manufactur- ing challenges, accelerate time to market, and mitigate risk for inhalation products with a range of properties. Experic, LLC US: +1 609 537-4040 www.expericservices.com DPI and nasal delivery formulation, device and manufacturing Hovione provides specialist expertise and leadership in particle engineering and formulation development to ensure that your inhalation and nasal therapies are engineered for success from start to finish. Fully inte- grated in one site, Hovione offers simple, patented and globally competitive dry powder inhalers—dispos- able, capsule, blister, large dose and high performance DPIs—which are available for fully integrated, turn- key development with formulation and for licensing. Expanding our inhalation offering, Hovione provides advanced nasal powder delivery devices, designed for local, systemic and nose-to-brain applications. Hovi- one—Delivering solutions, every breath of the way. Hovione Portugal: +351 21 982 9000 hovione.com/contact-us www.hovione.com